Combined hamartoma of the retina and retinal pigment epithelium

disease
On this page

Also known as CHR-RPEcombined hamartoma of the retina and RPE

Summary

Combined hamartoma of the retina and retinal pigment epithelium (MONDO:0018607) is a disease. A subtype of eye neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 7

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families120WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

7 HPO clinical features (Orphanet curated; top 7 by frequency):

HPO IDTermFrequency
HP:0000577ExotropiaVery frequent (80-99%)
HP:0000618BlindnessVery frequent (80-99%)
HP:0000579Nasolacrimal duct obstructionOccasional (5-29%)
HP:0007663Reduced visual acuityOccasional (5-29%)
HP:0007773VitreoretinopathyOccasional (5-29%)
HP:0012795Abnormality of the optic discOccasional (5-29%)
HP:0012841Retinal vascular tortuosityOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namecombined hamartoma of the retina and retinal pigment epithelium
Mondo IDMONDO:0018607
Orphanet440727
NCITC174548
UMLSC1862062
MedGen396281
GARD0021843
Is cancer (heuristic)no

Also known as: CHR-RPE · combined hamartoma of the retina and RPE

Disease family

This is a subtype of eye neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › disorder of orbital regioneye disordereye neoplasmcombined hamartoma of the retina and retinal pigment epithelium

Related subtypes (12): eyelid neoplasm, ocular cancer, ring dermoid of cornea, intraocular medulloepithelioma, orbital leiomyoma, conjunctival tumor, lacrimal gland neoplasm, uvea neoplasm, retina neoplasm, cornea neoplasm, benign neoplasm of eye, ocular surface squamous neoplasia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.